David P. Luci - Jan 3, 2024 Form 4 Insider Report for Acurx Pharmaceuticals, Inc. (ACXP)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ David P. Luci
Stock symbol
ACXP
Transactions as of
Jan 3, 2024
Transactions value $
$70,066
Form type
4
Date filed
1/4/2024, 04:24 PM
Previous filing
Feb 24, 2023
Next filing
Apr 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACXP Common Stock Options Exercise $70.1K +19.7K +1.92% $3.55 1.05M Jan 3, 2024 Direct
holding ACXP Common Stock 15.1K Jan 3, 2024 By spouse
holding ACXP Common Stock 35K Jan 3, 2024 By child

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACXP Warrants for Common Stock Options Exercise $0 -19.7K -100% $0.00* 0 Jan 3, 2024 Common Stock 19.7K $3.55 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.